{Reference Type}: Journal Article
{Title}: Ulinastatin inhibits the metastasis of nasopharyngeal carcinoma by involving uPA/uPAR signaling.
{Author}: Li CZ;Qiang YY;Liu ZJ;Zheng LS;Peng LX;Mei Y;Meng DF;Wei WW;Chen DW;Xu L;Lang YH;Xie P;Peng XS;Wang MD;Guo LL;Shu DT;Ding LY;Lin ST;Luo FF;Wang J;Li SS;Huang BJ;Chen JD;Qian CN;
{Journal}: Drug Dev Res
{Volume}: 84
{Issue}: 7
{Year}: 2023 11 3
{Factor}: 5.004
{DOI}: 10.1002/ddr.22098
{Abstract}: Distant metastasis is the primary reason for treatment failure in patients with nasopharyngeal carcinoma (NPC). In this study, we investigated the effect of ulinastatin (UTI) on NPC metastasis and its underlying mechanism. Highly-metastatic NPC cell lines S18 and 58F were treated with UTI and the effect on cell proliferation, migration, and invasion were determined by MTS and Transwell assays. S18 cells with luciferase-expressing (S18-1C3) were injected into the left hind footpad of nude mice to establish a model of spontaneous metastasis from the footpad to popliteal lymph node (LN). The luciferase messenger RNA (mRNA) was measured by quantitative polymerase chain reaction (qPCR), and the metastasis inhibition rate was calculated. Key molecular members of the UTI-related uPA, uPAR, and JAT/STAT3 signaling pathways were detected by qPCR and immunoblotting. UTI suppressed the migration and infiltration of S18 and 5-8F cells and suppressed the metastasis of S18 cells in vivo without affecting cell proliferation. uPAR expression decreased from 24 to 48 h after UTI treatment. The antimetastatic effect of UTI is partly due to the suppression of uPA and uPAR. UTI partially suppresses NPC metastasis by downregulating the expression of uPA and uPAR.